Prevalence of drug resistance mutations in Spain among both naive and pretreated patients.
Copyright policy )Prevalence of drug resistance mutations in Spain among both naive and pretreated patients.
The ERASE Spanish Study Group was founded in 1997 with the primary objective of monitoring both the prevalence and impact of the development of resistance to antiretroviral drugs in HIV-infected sentinel populations. Two major studies, one in 1997 and another in 1998, have been conducted so far. Global data and results derived from substudies are summarized in this presentation.
Adult, Male, Anti-HIV Agents, HIV Infections, Middle Aged, HIV Reverse Transcriptase, Cross-Sectional Studies, HIV Protease, Spain, Drug Resistance, Viral, Mutation, HIV-1, Prevalence, Humans, Reverse Transcriptase Inhibitors, Drug Therapy, Combination, Female
Adult, Male, Anti-HIV Agents, HIV Infections, Middle Aged, HIV Reverse Transcriptase, Cross-Sectional Studies, HIV Protease, Spain, Drug Resistance, Viral, Mutation, HIV-1, Prevalence, Humans, Reverse Transcriptase Inhibitors, Drug Therapy, Combination, Female
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).3 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!